Clinical Trial Update: Fluoxetine in Pediatric Body Dysmorphic Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial results have been posted for fluoxetine in pediatric body dysmorphic disorder. The study was sponsored by Montefiore Medical Center and has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Body Dysmorphic Disorder

Drugs mentioned

• Prozac (Fluoxetine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Body Dysmorphic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2015-06-29